A novel taxane, difluorovinyl-ortataxel, effectively overcomes paclitaxel-resistance in breast cancer cells.
Rong D, Wang C, Zhang X, Wei Y, Zhang M, Liu D, Farhan H, Momen Ali SA, Liu Y, Taouil A, Guo W, Wang Y, Ojima I, Yang S, Wang H.
Rong D, et al. Among authors: taouil a.
Cancer Lett. 2020 Oct 28;491:36-49. doi: 10.1016/j.canlet.2020.06.025. Epub 2020 Jul 27.
Cancer Lett. 2020.
PMID: 32730778